Skip to content

Reduced Port Laparoscopic Gastrectomy for Gastric Cancer

Comparison the Short and Long-term Outcome of Patients With Gastric Cancer Who Underwent Reduced Port Laparoscopic Gastrectomy With Patients Underwent Traditional Laparoscopic Gastrectomy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04295473
Enrollment
160
Registered
2020-03-04
Start date
2020-03-02
Completion date
2027-03-01
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrectomy, Laparoscopic

Brief summary

Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy

Detailed description

Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators designed a comparative study, which sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy. The short-term outcome include surgical complications, postoperative morbidity, postoperative nutrition. The long-term outcome mainly include long-term survival.

Interventions

PROCEDUREReduced port laparoscopic gastrectomy

The ports were reduced in the surgery of intervention arm.

Sponsors

Nanchong Central Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages. 2. Eastern Cooperative Oncology Group performance status of 0 or 1. 3. Adequate organ function.

Exclusion criteria

1. Patients had distant metastasis. 2. oesophageal invasion of more than 3 cm. 3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma. 4. Previous chemotherapy or radiation therapy for any other malignancies.

Design outcomes

Primary

MeasureTime frameDescription
5-year survival rate5 yearsLongterm survival for patients with gastrectomy after reduced port laparoscopic gastrectomy
3-year survival rate3 yearsSurvival rate for patients with gastrectomy after reduced port laparoscopic gastrectomy

Secondary

MeasureTime frameDescription
Postoperative morbidity rate6 monthsPostoperative morbidity rate for patients with gastrectomy after reduced port laparoscopic gastrectomy
Malnutrition rate6 monthsMalnutrition rate for patients with gastrectomy after reduced port
Quality of life in PGSAS-45 scale12 monthsThe quality of life were assessed using PGSAS-45 scale for patients with gastrectomy after reduced port laparoscopic gastrectomy.

Countries

China

Contacts

Primary ContactYunhong Tian, MD
drtianyunhong@126.com+86-13508087719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026